Current methods for laboratory diagnosis of rheumatoid arthritis

QR Code

Current methods for laboratory diagnosis of rheumatoid arthritis

Saved in:

Bibliographic Details
Main Authors:	A A Novikov, E N Aleksandrova, M V Cherkasova, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2010-02-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1243
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multiparameter analysis of biomarkers in the laboratory diagnosis of early rheumatoid arthritis
by: Aleksandr Aleksandrovich Novikov, et al.
Published: (2013-04-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

CURRENT APPROACHES TO THE LABORATORY DIAGNOSIS OF RHEUMATIC DISEASES: ROLE OF MOLECULAR AND CELLULAR BIOMARKERS
by: E. N. Aleksandrova, et al.
Published: (2016-07-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

The current standards for laboratory diagnosis of rheumatic diseases and their use in real clinical practice
by: Elena Nikolaevna Aleksandrova, et al.
Published: (2013-11-01)

USE OF MULTIPARAMETER ANALYSIS OF LABORATORY BIOMARKERS TO ASSESS RHEUMATOID ARTHRITIS ACTIVITY
by: A. A. Novikov, et al.
Published: (2016-02-01)

Role of cytokines in the pathogenesis of rheumatoid arthritis
by: Aleksandr Aleksandrovich Novikov, et al.
Published: (2010-04-01)

EFFICACY OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO ITS SERUM LEVEL AND THE PRESENCE OF ANTI-DRUG ANTIBODY
by: A. S. Avdeeva, et al.
Published: (2014-12-01)

ELABORATION AND APPLICATION OF THE DIAGNOSTIC INDEX BASED ON MULTIVARIATE ANALYSIS OF BIOMARKERS TO DETERMINE THE ACTIVITY OF RHEUMATOID ARTHRITIS
by: Aleksandr A Novikov, et al.
Published: (2014-03-01)

The 2015 guidelines for the laboratory diagnosis of rheumatic diseases by the All-Russian Public Organization «Association of Rheumatology of Russia»
by: E. N. Aleksandrova, et al.
Published: (2016-01-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

Metabolic syndrome in rheumatoid arthritis: role of adiponectin (preliminary results)
by: Yulia Nikolaevna Gorbunova, et al.
Published: (2013-11-01)

CYTOKINE LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN ASSOCIATION WITH LUNG INJURY
by: D. V. Bestaev, et al.
Published: (2014-09-01)

T-REGULATORY CELLS IN RHEUMATOID ARTHRITIS
by: E. L. Nasonov, et al.
Published: (2014-09-01)

Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy
by: A. S. Avdeeva, et al.
Published: (2021-09-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

Innovative technologies in the laboratory diagnosis of rheumatic diseases
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2010-04-01)

EFFECT OF RITUXIMAB ON THE BLOOD CHOLESTEROL TRANSPORT SYSTEM IN PATIENTSWITH RHEUMATOID ARTHRITIS
by: Tatyana Valentinovna Popkova, et al.
Published: (2010-08-01)

Predicting the development of rheumatoid arthritis in patients with early undifferentiated arthritis
by: E L Luchihina, et al.
Published: (2009-04-01)

CHANGES IN HEART RATE, HEART RATE VARIABILITY AND QT INTERVAL IN WOMEN WITH RHEUMATOID ARTHRITIS DURING RITUXIMAB TREATMENT
by: D. S. Novikova, et al.
Published: (2014-06-01)

CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01)

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Proinflammatory cytokines and depression in rheumatoid arthritis
by: Tatyana Andreyevna Lisitsyna, et al.
Published: (2013-06-01)

AN ASSOCIATION OF CYTOKINE LEVELS WITH DISEASE ACTIVITY, AUTOANTIBODY LEVELS, AND JOINT DESTRUCTIVE CHANGES IN EARLY RHEUMATOID ARTHRITIS
by: A. S. Avdeeva, et al.
Published: (2015-09-01)

Role of laboratory biomarkers in monitoring and prediction of the effectiveness of treatment of rheumatic diseases using genetically engineered drugs
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2014-03-01)

THE CLINICAL SIGNIFICANCE OF MATRIX METALLOPROTEINASES IN RHEUMATOID ARTHRITIS PATIENTS (REVIEW OF THE LITERATURE AND OUR OWN DATA)
by: Anastasiya S Avdeeva, et al.
Published: (2014-03-01)

CHANGES IN CALPROTECTIN LEVEL, ITS RELATIONSHIP TO THE CLINICAL AND LABORATORY PARAMETERS OF DISEASE ACTIVITY AND SIGNIFICANCE FOR PREDICTING THE THERAPEUTIC RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
by: A. O. Pchelintseva, et al.
Published: (2015-09-01)

IMMUNOLOGICAL EFFECTS OF A RITUXIMAB BIOSIMILAR (ACELBIA, BIOCAD) IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. S. Avdeeva, et al.
Published: (2018-11-01)

ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS AND ULTRASONIC SIGNS OF INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: O. G. Alekseeva, et al.
Published: (2016-02-01)

LABORATORY BIOMARKERS FOR ANKYLOSING SPONDYLITIS
by: E. N. Aleksandrova, et al.
Published: (2017-03-01)

Current practice of methotrexate treatment for rheumatoid arthritis
by: Yuri Vladimirovich Muravyev, et al.
Published: (2012-08-01)

B-lymphocyte hemostasis and anti-B-cell therapy areas for rheumatoid arthritis
by: Ekaterina Valeryevna Suponitskaya, et al.
Published: (2013-11-01)

Immunological effects of adalimumab in rheumatoid arthritis: Results of a Russian national study
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-06-01)

IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDY
by: M. S. Naumtseva, et al.
Published: (2017-01-01)

Efficacy and safety of Tofacitinib in patients with active rheumatoid arthritis resistant to conventional therapy: Preliminary results of an open-label clinical trial
by: E. L. Luchikhina, et al.
Published: (2016-06-01)

Dynamics of lymphocyte subpopulations, CD4+CD25+CD127- T regulatory cells in patients with rheumatoid arthritis during therapy with the rituximab biosimilar Acellbia
by: A. S. Avdeeva, et al.
Published: (2020-05-01)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)